Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study.
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study.
复制标题
DOI:
10.1093/cid/ciab072
复制
发表时间:
2021-08-02
期刊:
影响因子:
--
通讯作者:
Haidar G
中科院分区:
文献类型:
--
作者:
Hensley MK;Bain WG;Jacobs J;Nambulli S;Parikh U;Cillo A;Staines B;Heaps A;Sobolewski MD;Rennick LJ;Macatangay BJC;Klamar-Blain C;Kitsios GD;Methé B;Somasundaram A;Bruno TC;Cardello C;Shan F;Workman C;Ray P;Ray A;Lee J;Sethi R;Schwarzmann WE;Ladinsky MS;Bjorkman PJ;Vignali DA;Duprex WP;Agha ME;Mellors JW;McCormick KD;Morris A;Haidar G
A chimeric antigen receptor-modified T-cell therapy recipient developed severe coronavirus disease 2019, intractable RNAemia, and viral replication lasting >2 months. Premortem endotracheal aspirate contained >2 × 1010 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA copies/mL and infectious virus. Deep sequencing revealed multiple sequence variants consistent with intrahost virus evolution. SARS-CoV-2 humoral and cell-mediated immunity were minimal. Prolonged transmission from immunosuppressed patients is possible.
登录
查看更多内容
影响因子:
11.8
作者:
Veyer, David;Kerneis, Solen;Pere, Helene
通讯作者:
Pere, Helene
影响因子:
11.8
作者:
Xiao, Ai Tang;Tong, Yi Xin;Zhang, Sheng
通讯作者:
Zhang, Sheng
影响因子:
158.5
作者:
Gudbjartsson, Daniel F.;Norddahl, Gudmundur L.;Stefansson, Kari
通讯作者:
Stefansson, Kari
影响因子:
11.8
作者:
Waghmare, Alpana;Campbell, Angela P.;Boeckh, Michael
通讯作者:
Boeckh, Michael
DOI:
10.1158/1078-0432.ccr-12-2422
发表时间:
2013-04-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Carpenter RO;Evbuomwan MO;Pittaluga S;Rose JJ;Raffeld M;Yang S;Gress RE;Hakim FT;Kochenderfer JN
通讯作者:
Kochenderfer JN